VivoSim Labs (VIVS)

• Market cap: $1.2M
• 1 day: -10.73%
• 5 days: -12.32%
• 1 month: -67.79%
• 3 months: -75.9%
• 6 months: -85.82%
• Year to date: -81.67%
• 1 year: -81.57%
• 5 years: -99.64%
• 10 years: -99.97%
• Sector: Healthcare
• Industry: Biotechnology

About: VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Employees: 15